Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Plug Power Inc (PLUG) Price & Performance

Novartis AGTrade
Plug Power IncTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Plug Power Inc — how do they compare? Novartis AG trades at $138.17 (market cap $262.64B), while Plug Power Inc trades at $2.19 (market cap $3.16B). The key difference: Novartis AG is far larger — about 83.1× Plug Power Inc's market cap, and Novartis AG pays a 3.44% dividend while Plug Power Inc pays none. Which is the better fit depends on your goals.

NVSPLUG
Market Cap
$262.64B$3.16B
Sector
HealthIndustrials
52-Week High
$168.62$4.14
52-Week Low
$121.80$1.44
Enterprise Value
$303.97B$4.03B
Dividend Yield
3.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novartis AG

Novartis (NVS) is trading at $137.70, down 13.93% following significant clinical trial setbacks for del-desiran and pelacarsen. The stock shows bearish technical signals with support at $133-$136 and resistance at $140-$143. Fundamentally, the company maintains strong profitability with 74.74% gross margins and 22.5% net income margins, though recent pipeline failures have overshadowed solid financial performance.

While Novartis maintains strong financial fundamentals and reiterated 2025-2030 growth guidance, the recent clinical trial failures create near-term uncertainty. The stock faces pressure from pipeline setbacks but offers value at current levels for long-term investors willing to weather development risks. Analyst consensus remains cautious with 68% hold ratings.

Plug Power Inc

Plug Power (PLUG) trades at $2.26, up 4.15% today, but remains in a challenging fundamental position with persistent losses. The company shows modest revenue recovery to $710 million in 2025 but continues to report negative gross margins and substantial net losses. Technical indicators suggest a bullish short-term trend, while analyst sentiment remains divided with a $4.04 consensus price target representing significant upside potential from current levels.

While PLUG offers substantial upside based on analyst targets and growing electrolyzer demand, the investment carries high risk due to ongoing operational losses, negative cash flow, and heavy reliance on financing. The company's turnaround strategy shows early progress but requires sustained execution to achieve profitability amid competitive pressures in the hydrogen sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Plug Power Inc

Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.

Read more on PLUG